Nice op-ed from @polybiorf.bsky.social on the need for more Long COVID trials.

Proud to have been a part of this
@polybiorf.bsky.social effort to describe the path forward for #LongCOVID trials targeting SARS-CoV-2 persistence. We need a robust biomarker development program and to launch more trials to rigorously test treatments that target these pathways now.